Subscribe     Pay Now

Israel Project Notice - A Natural And High Quality Ingredient For Dietary Supplement Derived From Yeast Fermentation To Reduce Oxidative Stress And Promote Health And Wellbeing


Project Notice

PNR 33184
Project Name A natural and high quality ingredient for dietary supplement derived from yeast fermentation to reduce oxidative stress and promote health and wellbeing
Project Detail Oxidative stress is an imbalance between the production of reactive oxygen species and the ability of the human body to counteract their harmful effects through neutralization by antioxidants. Oxidative stress is the major cause of the cellular damage at the basis of age-related diseases, such as atherosclerosis, cancer, diabetes, rheumatoid arthritis, cardiovascular diseases, chronic inflammations, stroke and other degenerative diseases. The best way to reduce oxidative stress is the intake of antioxidants. Astaxanthin (AST) is the most effective natural antioxidant used to quench oxidative stress. However, the efficacy of AST currently available on the market is very low, due to its poor concentration, and only suitable for a limited number of applications due to its unpleasant flavour and odour. NextFerm offers AstaFerm™, the most effective anti-oxidant dietary supplement made of natural Astaxanthin. AstaFerm™ is an ingredient for dietary supplement composed of an Astaxanthin-rich extract derived from the fermented biomass of yeast strain. AstaFerm™ proprietary process represents the most efficient, innovatory, and sustainable way to produce a natural, high quality and bio-available form of Astaxanthin, with a neutral flavour and odour. The results are highly concentrated AST crystals that can be refined in multiple applications which today are not available on the market. During the phase 1 project, a go-to-market strategy and a supply chain will be established, as well as further development plan will be drafted. Within the overall innovation project NextFerm will optimise the extraction process of AstaFerm™ before scaling up and perform clinical studies.
Funded By European Union (EU)
Sector Health & Medical
Country Israel , Western Asia
Project Value ILS 71,429

Contact Information

Company Name NEXTFERM TECHNOLOGIES LTD
Address 7 Hakidma St. 2069208 Yokneam Ilit
Web Site https://cordis.europa.eu/project/rcn/224549/factsheet/en

Tell us about your Product / Services,
We will Find Tenders for you